Manufacturer copay assistance · Veklury (J0248) · Gilead
Reduced cost for… · Maximum benefit Up to ~$9,500 lifetime maximum · Covers Veklury drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Veklury — check the full fund board.
Run a benefits estimate for Veklury — the program's cap applies against the patient share CareCost calculates.
Yes — Gilead Advancing Access Co-pay Program from Gilead. Reduced cost for eligible patients. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Reduced cost for eligible patients Maximum benefit: Up to ~$9,500 lifetime maximum. Covers Veklury drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.